INTECH Investment Management’s Akebia Therapeutics AKBA Stock Holding History

INTECH Investment Management’s Portfolio AKBA Stock Details AKBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$70.9K	Sell	62,220 -3,845	-6%	-$4.58K	﹤0.01%	2003
2026 Q1	$91.8K	Sell	66,065 -37,322	-36%	-$51.3K	﹤0.01%	1909
2025 Q4	$166K	Buy	103,387 +1,418	+1%	+$2.97K	﹤0.01%	2039
2025 Q3	$278K	Sell	101,969 -40,959	-29%	-$136K	﹤0.01%	1871
2025 Q2	$520K	Buy	142,928 +15,569	+12%	+$42.8K	﹤0.01%	1592
2025 Q1	$245K	Buy	127,359 +9,150	+8%	+$18.7K	﹤0.01%	1987
2024 Q4	$225K	Buy	118,209 +73,143	+162%	+$127K	﹤0.01%	1976
2024 Q3	$59.5K	Buy	+45,066	New	+$60.2K	﹤0.01%	1966

Other funds holding AKBA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

INTECH Investment Management's AKBA Position: Q2 2026 in Review

INTECH Investment Management reduced its Akebia Therapeutics (AKBA) stake by 5.8% in Q2 2026, selling an estimated $4.58K and leaving 62,220 shares worth $70.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2003.

INTECH Investment Management first reported a position in AKBA in Q3 2024 and has held it in 8 quarters since. The position peaked at $520K in Q2 2025. 171 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

INTECH Investment Management held 62,220 shares of Akebia Therapeutics worth $70.9K as of Q2 2026.
INTECH Investment Management sold 3,845 Akebia Therapeutics shares in Q2 2026, an estimated $4.58K.
Akebia Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #2003 holding.
INTECH Investment Management first reported a position in Akebia Therapeutics in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Akebia Therapeutics position peaked at $520K in Q2 2025.
171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.